Search results

Global COVID vaccine roll-out will face many hurdles

Location:

INT

Initial data are expected to become available before the end of the year, and subject to evidence of safety and efficacy, to be submitted for approval and fast-tracked so that a…

Vaccine woes will deepen polarisation in Argentina

Location:

ARGENTINA

A rise in cases and deaths has increased pressure on the government over its sluggish vaccine roll-out. Despite an announcement recently that a local laboratory will soon begin…

Organised crime will gain from world vaccine shortages

Location:

INT

However, it is vast global demand for the restricted supply of COVID-19 vaccines that offers the most alluring prize for criminal gangs. Black markets thrive in situations where…

India will not revive vaccine shipments until 2022

Location:

INDIA

India suspended its ‘vaccine diplomacy’ in April, choosing to prioritise shots for its own population, as it came under pressure from a massive second wave of COVID-19 infections…

Central America’s vaccine efforts face mixed prospects

Location:

CENTRAL AMERICA

Elsewhere in the region, only Panama has so far received a first vaccine shipment, suggesting roll-outs initially will be patchy. Central American governments are sourcing their…

India’s key vaccine challenge is at home, not abroad

Location:

INDIA

Its vaccine production capacity has increased in the intervening period to the extent that it now has a surplus of doses, even allowing for supplies abroad. A key reason why so…

Malaria vaccine could pave the way for global advances

Location:

INTERNATIONAL

Implications of the first malaria vaccine to complete human testing.

Vaccine success will be rare boon for Havana

Location:

CUBA

Effectiveness rates from phase III trials have been excellent, prompting sceptics to question the trustworthiness of the data. The country’s ongoing vaccination campaign…

India’s vaccine roll-out faces key obstacles

Location:

INDIA

Earlier this month, the Drugs Controller General of India (DCGI) approved the Oxford/AstraZeneca vaccine, marketed in India as ‘Covishield’, and a locally developed jab. The…

India may again lean on its COVID-19 vaccine producers

Location:

INDIA

The health ministry reports that there are fewer than 2,000 active coronavirus cases in the country, a miniscule number relative to the size of the population, but the authorities…